Search for: "Mylan Pharmaceuticals"
Results 361 - 380
of 739
Sorted by Relevance
|
Sort by Date
14 Apr 2015, 8:34 pm
The Federal Circuit found that Apotex has a concrete, potentially high-value stake in obtaining a declaratory judgment, and that both Daiichi and generic manufacturer Mylan Pharmaceuticals, Inc. have a concrete, potentially high-value stake in denying Apotex that judgment and thereby delaying Apotex’s market entry. [read post]
19 Apr 2010, 11:39 am
It details the activities and successes of NY's MFCU.The report highlights Operation Home Alone, an investigation of corruption in the home care industry; settlements with several pharmaceutical companies, including Eli Lilly, Pfizer, Mylan Pharmaceuticals, Astra Zeneca, and Aventis for off-label marketing, kickbacks, misreporting prices, and other fraud; nursing home fraud investigations; and other types of program fraud. [read post]
25 Feb 2018, 11:45 am
Mylan had instituted inter partes review (IPR) proceedings against Allergan back in December 2016. [read post]
12 Dec 2008, 7:00 am
EU: European Commission preliminary report on its inquiry into competition in the pharmaceutical sector (Spicy IP) (Intellectual Property Watch) (Patent Baristas) EU: Enlarged Board of the EPO denies WARF’s patent application directed to human embryonic stem cells (Patent Docs) US: Patent Office assault on pharma industry (PLI) US: Proponent of gene patent ban Rep Xavier Becerra to leave Congress (Patent Docs) US: Merck & Co starts generic arm BioVentures to copy biologic… [read post]
8 Nov 2007, 9:00 pm
Due to popular demand, I will have a separate section for Pharmaceutical Industry items from this week. [read post]
24 Oct 2018, 1:47 pm
Mylan Pharmaceuticals Inc., App. [read post]
29 Mar 2011, 9:19 pm
General Pharmaceutical, biotechnology and chemical inventions – world protection and exploitation (FDA Law Blog) Gene patents on the high seas: who owns the ocean’s IP? [read post]
31 Oct 2011, 6:46 am
Lately, we've been thinking about generic pharmaceuticals and preemption. [read post]
14 Apr 2014, 3:51 pm
The generic firms — Sandoz Inc., Momenta Pharmaceuticals, Inc., Mylan Pharmaceuticals, Inc., and Natco Pharma Ltd. [read post]
26 Apr 2011, 11:15 pm
Mylan, Inc.is a generic pharmaceutical company and distributes Amnesteem, a form of isotretinoin, which presently remains in stores. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
19 Oct 2017, 10:29 am
” Generic drug manufacturers Teva Pharmaceuticals USA, Inc.; Akorn, Inc.; Mylan, Inc.; and Mylan Pharmaceuticals, Inc., that wish to manufacture and sell bioequivalent drugs having the same components as Restasis challenged that the patents asserted by Allergan are invalid in defense to a patent infringement suit filed by Allergan. [read post]
10 Jun 2020, 8:10 am
The patent is licensed to Flynn Pharmaceuticals. [read post]
9 Apr 2010, 8:30 am
These companies include Mylan Pharmaceuticals Inc., Roxane Laboratories Inc., and Torrent Pharmaceuticals Ltd. [read post]
15 Dec 2016, 11:44 am
(Paul Buckowski / Times Union) Heritage Pharmaceuticals, Aurobindo Pharma USA, Citron Pharma, Mayne Pharma, Mylan Pharmaceuticals and Teva Pharmaceuticals USA are being targeted by the lawsuit. [read post]
17 Oct 2011, 11:24 am
(Mylan) filed an action to try to invalidate a Supplementary Protection Certificate (“SPC”) for a drug for the treatment of Alzheimer’s disease called rivastigmine. [read post]
27 Dec 2012, 3:47 pm
Mylan Pharmaceuticals, Inc., 2012 WL 170143, at *5 (S.D. [read post]
17 Jun 2011, 2:25 am
The Bedford Report keeps an eye on healthcare companies and provides research reports on Teva Pharmaceutical Industries Limited (makers of generic Yasmin) and Mylan Inc., the makers of Effexor. [read post]
6 Sep 2011, 11:24 pm
Mylan Pharmaceuticals, the makers of the controversial antidepressant Paxil, is trying to negotiate with the FDA as well as other generic drug manufacturers to pay an astonishing $299 million every year for the inspections of their foreign facilities — this according to reports by ABC News. [read post]
21 May 2007, 3:26 pm
Mylan lost that case and appealed to the D.C. [read post]
